Combined modality therapy for local advanced non-small cell lung cancer
Bin Zhang
Abstract
Bin Zhang
Abstract
This paper reviews the latest developments in radiotherapy, chemotherapy and chemoradiotherapy for local advanced non-small cell lung cancer in the past years. Radiotherapy, includes conventional fractionated radiotherapy, accelerated hyperf-raction radiotherapy and three-dimensional radiotherapy etc.Chemotherapy, includes the analysis of effects of various chemotherapeutic regimens, recommending the reasonable methods of chemotherapy and chemoradiotherapy and the development of molecular targeted therapy. Sequential chemoradiotherapy and concurrent chemoradiotherapy show advantagement chemoradiotherapy on the local control rate and survival rate. Key words: Carcinoma, non-small-cell lung; Radiotherapy; Drug therapy; Combined modality therapy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This paper reviews the latest developments in radiotherapy, chemotherapy and chemoradiotherapy for local advanced non-small cell lung cancer in the past years. Radiotherapy, includes conventional fractionated radiotherapy, accelerated hyperf-raction radiotherapy and three-dimensional radiotherapy etc.Chemotherapy, includes the analysis of effects of various chemotherapeutic regimens, recommending the reasonable methods of chemotherapy and chemoradiotherapy and the development of molecular targeted therapy. Sequential chemoradiotherapy and concurrent chemoradiotherapy show advantagement chemoradiotherapy on the local control rate and survival rate. Key words: Carcinoma, non-small-cell lung; Radiotherapy; Drug therapy; Combined modality therapy
Key concepts: Radiation therapy, Chemoradiotherapy, Medicine, Lung cancer, Chemotherapy, Oncology, Internal medicine